Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1975
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1978 1
1979 1
1980 3
1981 1
1984 1
1985 2
1986 2
1987 3
1988 1
1989 8
1990 12
1991 5
1992 12
1993 4
1994 5
1995 12
1996 10
1997 11
1998 11
1999 18
2000 13
2001 20
2002 9
2003 15
2004 15
2005 21
2006 20
2007 21
2008 20
2009 16
2010 24
2011 12
2012 13
2013 18
2014 28
2015 22
2016 27
2017 20
2018 23
2019 19
2020 30
2021 28
2022 24
2023 30
2024 21
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

577 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Testing in Breast Cancer.
Litton JK, Burstein HJ, Turner NC. Litton JK, et al. Am Soc Clin Oncol Educ Book. 2019 Jan;39:e1-e7. doi: 10.1200/EDBK_237715. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099622 Free article. Review.
Molecular testing for genetic and genomic variation has become an integral part of breast cancer management. Patients with a family history of breast cancer or other tumors, bilateral breast cancers, or early-onset breast cancers warrant genetic …
Molecular testing for genetic and genomic variation has become an integral part of breast cancer management. Patients with a family h …
Breast cancer prevention in high-risk women.
Thorat MA, Balasubramanian R. Thorat MA, et al. Best Pract Res Clin Obstet Gynaecol. 2020 May;65:18-31. doi: 10.1016/j.bpobgyn.2019.11.006. Epub 2019 Nov 21. Best Pract Res Clin Obstet Gynaecol. 2020. PMID: 31862315 Review.
Bilateral Risk-Reducing Mastectomy (BRRM) reduces the risk of developing breast cancer by 90% in high-risk women such as carriers of BRCA mutations. It also improves breast cancer-specific survival in BRCA1 carriers. Bilateral risk-reducing salpingo-oo
Bilateral Risk-Reducing Mastectomy (BRRM) reduces the risk of developing breast cancer by 90% in high-risk women such as carri
Menopausal hormone therapy and breast cancer risk.
Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C. Rozenberg S, et al. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101577. doi: 10.1016/j.beem.2021.101577. Epub 2021 Sep 10. Best Pract Res Clin Endocrinol Metab. 2021. PMID: 34535397 Review.
Carriers of BRCA 1 & 2 mutation after risk-reducing bilateral salpingo-oophorectomy (RRSO), without a personal history of cancer, have an increased breast cancer risk, but may probably be treated with MHT till the age of 50. ...In peri- and postmenopausal women …
Carriers of BRCA 1 & 2 mutation after risk-reducing bilateral salpingo-oophorectomy (RRSO), without a personal history of cancer, …
Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions.
Tan WJT, Vlajkovic SM. Tan WJT, et al. Int J Mol Sci. 2023 Nov 20;24(22):16545. doi: 10.3390/ijms242216545. Int J Mol Sci. 2023. PMID: 38003734 Free PMC article. Review.
Cisplatin is a commonly used chemotherapeutic agent with proven efficacy in treating various malignancies, including testicular, ovarian, cervical, breast, bladder, head and neck, and lung cancer. Cisplatin is also used to treat tumors in children, such as neuroblastoma, o …
Cisplatin is a commonly used chemotherapeutic agent with proven efficacy in treating various malignancies, including testicular, ovarian, ce …
Nipple-sparing and skin-sparing mastectomy: Review of aims, oncological safety and contraindications.
Galimberti V, Vicini E, Corso G, Morigi C, Fontana S, Sacchini V, Veronesi P. Galimberti V, et al. Breast. 2017 Aug;34 Suppl 1(Suppl 1):S82-S84. doi: 10.1016/j.breast.2017.06.034. Epub 2017 Jun 30. Breast. 2017. PMID: 28673535 Free PMC article. Review.
Skin-sparing (SSM) and nipple-sparing (NSM) mastectomies are relatively new conservative surgical approaches to breast cancer. In SSM most of the breast skin is conserved to create a pocket that facilitates immediate breast reconstruction with implant or auto …
Skin-sparing (SSM) and nipple-sparing (NSM) mastectomies are relatively new conservative surgical approaches to breast cancer. In SSM …
Risk-reducing mastectomy for the prevention of primary breast cancer.
Carbine NE, Lostumbo L, Wallace J, Ko H. Carbine NE, et al. Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD002748. doi: 10.1002/14651858.CD002748.pub4. Cochrane Database Syst Rev. 2018. PMID: 29620792 Free PMC article. Review.
OBJECTIVES: (i) To determine whether risk-reducing mastectomy reduces death rates from any cause in women who have never had breast cancer and in women who have a history of breast cancer in one breast, and (ii) to examine the effect of risk-reducing mastecto …
OBJECTIVES: (i) To determine whether risk-reducing mastectomy reduces death rates from any cause in women who have never had breast c …
Bilateral breast cancers.
Narod SA. Narod SA. Nat Rev Clin Oncol. 2014 Mar;11(3):157-66. doi: 10.1038/nrclinonc.2014.3. Epub 2014 Feb 4. Nat Rev Clin Oncol. 2014. PMID: 24492834 Review.
An increasingly large proportion of women with unilateral breast cancer are treated with bilateral mastectomy. The rationale behind bilateral surgery is to prevent a second primary breast cancer and thereby to avoid the resultant therapy and eliminate …
An increasingly large proportion of women with unilateral breast cancer are treated with bilateral mastectomy. The rationale b …
High-quality breast MRI.
Hendrick RE. Hendrick RE. Radiol Clin North Am. 2014 May;52(3):547-62. doi: 10.1016/j.rcl.2013.12.002. Epub 2014 Jan 21. Radiol Clin North Am. 2014. PMID: 24792656 Review.
Breast magnetic resonance imaging (MRI) demands the competing factors of high spatial resolution, good temporal resolution, high signal-to-noise ratios, and complete bilateral breast coverage. ...This article discusses the equipment and pulse sequences needed
Breast magnetic resonance imaging (MRI) demands the competing factors of high spatial resolution, good temporal resolution, high sign
Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients.
De la Cruz Ku G, Karamchandani M, Chambergo-Michilot D, Narvaez-Rojas AR, Jonczyk M, Príncipe-Meneses FS, Posawatz D, Nardello S, Chatterjee A. De la Cruz Ku G, et al. Ann Surg Oncol. 2022 Oct;29(10):6163-6188. doi: 10.1245/s10434-022-12133-8. Epub 2022 Jul 25. Ann Surg Oncol. 2022. PMID: 35876923 Review.
We excluded studies that included male sex, stage 0, distant metastasis at diagnosis, bilateral synchronous cancer, neoadjuvant radiation/chemotherapy, and articles with incomplete data. ...Such results depicting survival advantage, especially using such a large sample of …
We excluded studies that included male sex, stage 0, distant metastasis at diagnosis, bilateral synchronous cancer, neoadjuvant radia …
Adrenal metastases.
Wagnerova H, Lazurova I, Felsoci M. Wagnerova H, et al. Bratisl Lek Listy. 2013;114(4):237-40. doi: 10.4149/bll_2013_049. Bratisl Lek Listy. 2013. PMID: 23514559 Review.
The adrenal gland is a frequent location for metastatic spread of a various number of malignant tumors. Among all tumors, carcinoma of lung, breast, ovary and malignant melanoma count to the most frequent ones. ...The examination of adrenal overproduction is not nec …
The adrenal gland is a frequent location for metastatic spread of a various number of malignant tumors. Among all tumors, carcinoma o …
577 results